Description
Job Description Medical Science Liaison (MSL), Oncology (Skin Cancers) Territory: Central and Western United States Role Overview The MSL, Oncology (Skin Cancers) will join a fast-growing Field Medical Affairs team focused on commercializing the novel Signatera™ molecular residual disease (MRD) test. This role is dedicated to supporting oncologists and cancer researchers across solid tumors—with a primary emphasis on skin cancers—alongside complementary products and services within Natera's oncology portfolio. In 2019, the FDA designated Signatera as a Breakthrough Device, and Medicare proposed coverage for its use in patients with Stage II–III colorectal cancer as its first indication. We are seeking a smart, mission-oriented Medical Affairs professional who can communicate effectively to help transform the management of cancer worldwide. The MSL serves as a vital field-based scientific resource for clinicians, academic institutions, and professional organizations. Primary Responsibil...
Ready to Seal the Deal?
Submit your application today and take the next step in your career with Natera.
Apply for this Job